Raia Drogasil (RADLY) Set to Release Earnings on Tuesday

Raia Drogasil (OTCMKTS:RADLY) is anticipated to release its results after the market closes on Tuesday, November 3rd. Analysts expect Raia Drogasil to announce earnings of $0.05 per share and revenue of $2.41 billion for the quarter.

Raia Drogasil (OTCMKTS:RADLY) last released its quarterly earnings results on Tuesday, August 4th. The company reported $0.05 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.05. Raia Drogasil had a return on equity of 20.12% and a net margin of 2.99%. The business had revenue of $2.17 billion during the quarter, compared to the consensus estimate of $2.32 billion. On average, analysts expect Raia Drogasil to post $0.17 EPS for the current fiscal year and $0.24 EPS for the next fiscal year.

Raia Drogasil Stock Performance

Shares of OTCMKTS RADLY traded down $0.15 during midday trading on Tuesday, hitting $2.85. 187,774 shares of the company’s stock traded hands, compared to its average volume of 180,914. Raia Drogasil has a 1 year low of $2.80 and a 1 year high of $5.34. The stock has a market capitalization of $3.75 billion and a price-to-earnings ratio of 19.00. The company has a debt-to-equity ratio of 0.99, a quick ratio of 0.58 and a current ratio of 1.41. The firm has a fifty day moving average of $3.80 and a 200 day moving average of $4.12.

Analyst Ratings Changes

Separately, Jefferies Financial Group raised shares of Raia Drogasil to a “buy” rating and set a $5.20 price objective on the stock in a report on Sunday, October 18th. One equities research analyst has rated the stock with a Buy rating and one has issued a Hold rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $5.20.

Raia Drogasil Company Profile

Raia Drogasil, now operating under the name RD Saúde, is a Brazilian healthcare and pharmacy retail company. It operates a network of pharmacies offering prescription medicines, over-the-counter drugs, vitamins, personal care products, beauty items and other health-related merchandise.

The company also provides digital purchasing and delivery services through its online channels, supporting customers with prescription fulfillment, health products and related services. Its operations include pharmacy-based healthcare initiatives designed to complement its retail business and improve access to everyday healthcare.

RD Saúde was created in 2011 through the merger of Drogasil and Droga Raia, two established Brazilian pharmacy chains.